Risk of cardiovascular events associated with selective COX-2 inhibitors.

@article{Mukherjee2001RiskOC,
  title={Risk of cardiovascular events associated with selective COX-2 inhibitors.},
  author={D. Mukherjee and S. Nissen and E. Topol},
  journal={JAMA},
  year={2001},
  volume={286 8},
  pages={
          954-9
        }
}
Atherosclerosis is a process with inflammatory features and selective cyclooxygenase 2 (COX-2) inhibitors may potentially have antiatherogenic effects by virtue of inhibiting inflammation. However, by decreasing vasodilatory and antiaggregatory prostacyclin production, COX-2 antagonists may lead to increased prothrombotic activity. To define the cardiovascular effects of COX-2 inhibitors when used for arthritis and musculoskeletal pain in patients without coronary artery disease, we performed a… Expand
1,190 Citations

Paper Mentions

Interventional Clinical Trial
The study is going to compare two different doses of aspirin for the treatment of heart disease in combination with the anticlotting medication ticagrelor. One of these doses of… Expand
ConditionsAcute Coronary Syndrome
InterventionDrug
COX-2 Inhibitors and Cardiovascular Risk
  • 76
Cyclooxygenase-2 Inhibition and Coagulation
  • 28
Cardiovascular hazard and non-steroidal anti-inflammatory drugs.
  • 96
Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?
  • 13
Cardiovascular effects of the selective cyclooxygenase-2 inhibitors.
  • W. White
  • Medicine
  • Sub-cellular biochemistry
  • 2007
  • 11
  • PDF
Cyclooxygenase-2 inhibitors: Is there an association with coronary or renal events?
  • R. Bing
  • Medicine
  • Current atherosclerosis reports
  • 2003
  • 21
Understanding the NSAID related risk of vascular events
  • 36
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
Outcome of specific COX-2 inhibition in rheumatoid arthritis.
  • 112
The Cyclooxygenase-2 Inhibitors: Safety and Effectiveness
  • 93
Anti-inflammatory drugs and their mechanism of action
  • 578
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.
  • 613
  • PDF
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor
  • 294
Inflammation and Coronary Heart Disease: An Overview
  • 114
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
  • 368
  • PDF
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
  • 7,291
...
1
2
3
4
5
...